TW
CALC icon

TritonPoint Wealth’s CalciMedica CALC Stock Holding History

TritonPoint Wealth’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,024
Closed -$46.5K – 287
2025
Q3 		$46.5K Hold
3,024
– – ﹤0.01% 349
2025
Q2 		$24.2K Hold
3,024
– – ﹤0.01% 343
2025
Q1 		$28.9K Hold
3,024
– – ﹤0.01% 337
2024
Q4 		$53.5K Hold
3,024
– – ﹤0.01% 331
2024
Q3 		$64.1K Hold
3,024
– – 0.01% 328
2024
Q2 		$59.9K Buy
+3,024
New +$76.2K 0.01% 316

Other funds holding CALC

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.93B AUM 16.26% 1-Year Est. Return

TritonPoint Wealth's CALC Position: Q4 2025 in Review

TritonPoint Wealth sold out of CalciMedica (CALC) in Q4 2025, closing a stake of 3,024 shares — an estimated $46.5K sold.

TritonPoint Wealth first reported a position in CALC in Q2 2024 and held it in 6 quarters. The position peaked at $64.1K in Q3 2024. 31 funds tracked by Wall St. Rank hold CALC as of Q4 2025.

  • TritonPoint Wealth reported no remaining CalciMedica position as of Q4 2025 after selling out during the quarter.
  • TritonPoint Wealth sold 3,024 CalciMedica shares in Q4 2025, an estimated $46.5K.
  • TritonPoint Wealth first reported a position in CalciMedica in Q2 2024 and held it in 6 quarters.
  • TritonPoint Wealth's CalciMedica position peaked at $64.1K in Q3 2024.
  • 31 funds tracked by Wall St. Rank held CalciMedica as of Q4 2025.

Based on TritonPoint Wealth's 13F filing for Q4 2025, filed 20 Jan 2026.